Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration

Sustained Increased Intraocular Pressure Related to Intravitreal Antivascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration

(2011) Joseph J. Tseng et al.   JOURNAL OF GLAUCOMA

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents

(2010) T. J. Good et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application

(2010) Fabian Höhn et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections

(2010) Ron A. Adelman et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

HIGH-MOLECULAR-WEIGHT AGGREGATES IN REPACKAGED BEVACIZUMAB

(2010) Malik Y Kahook et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Sustained Elevation in Intraocular Pressure Associated with Intravitreal Bevacizumab Injections

(2009) Malik Y. Kahook et al.   OPHTHALMIC SURGERY LASERS & IMAGING

Persisent ocular hypertension following intravitreal ranibizumab

(2008) Sophie J. Bakri et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Intraocular inflammation following intravitreal injection of bevacizumab

(2008) Sophie J. Bakri et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY